SevenBridge Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

SevenBridge Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-37	Closed	-$5K	–	368
2019 Q2	$5K	Hold	37	–	–	﹤0.01%	519
2019 Q1	$5K	Hold	37	–	–	﹤0.01%	487
2018 Q4	$5K	Hold	37	–	–	﹤0.01%	445
2018 Q3	$6K	Hold	37	–	–	﹤0.01%	468
2018 Q2	$6K	Hold	37	–	–	﹤0.01%	477
2018 Q1	$6K	Hold	37	–	–	﹤0.01%	485
2017 Q4	$5K	Hold	37	–	–	﹤0.01%	511
2017 Q3	$5K	Sell	37 -175	-83%	-$26.5K	﹤0.01%	508
2017 Q2	$33K	Hold	212	–	–	0.02%	319
2017 Q1	$33K	Hold	212	–	–	0.02%	311
2016 Q4	$26K	Hold	212	–	–	0.02%	327
2016 Q3	$26K	Hold	212	–	–	0.02%	326
2016 Q2	$30K	Buy	+212	New	+$31.3K	0.02%	347

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SevenBridge Financial Group's JAZZ Position: Q3 2019 in Review

SevenBridge Financial Group sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2019, closing a stake of 37 shares — an estimated $5K sold.

SevenBridge Financial Group first reported a position in JAZZ in Q2 2016 and held it in 13 quarters. The position peaked at $33K in Q2 2017. 406 funds tracked by Wall St. Rank hold JAZZ as of Q3 2019.

SevenBridge Financial Group reported no remaining Jazz Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
SevenBridge Financial Group sold 37 Jazz Pharmaceuticals shares in Q3 2019, an estimated $5K.
SevenBridge Financial Group first reported a position in Jazz Pharmaceuticals in Q2 2016 and held it in 13 quarters.
SevenBridge Financial Group's Jazz Pharmaceuticals position peaked at $33K in Q2 2017.
406 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2019.

Based on SevenBridge Financial Group's 13F filing for Q3 2019, filed 9 Oct 2019.